Pyxis Oncology Competitors and Similar CompaniesClear all
Pyxis Oncology's competitors and similar companies include TriSalus Life Sciences, Farmabios, ChemoCentryx and Sunshine Biopharma.
 Pyxis Oncology Pyxis Oncology is a preclinical oncology company focused on developing therapeutics to target difficult-to-treat cancers. |  TriSalus Life Sciences TriSalus Life Sciences (formerly MedTech Acquisition and Surefire Medical) is a company that develops a transformative platform for treating liver and pancreatic tumors. |  ChemoCentryx ChemoCentryx is a biopharmaceutical company commercializing and developing medications for inflammatory and autoimmune diseases and cancer. |  Sunshine Biopharma Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer. | ||
Founding Date | Founding Date 2019 | Founding Date 2009 | Founding Date 1961 | Founding Date 1997 | Founding Date 2006 |
Type | Type Public | Type Public | Type Subsidiary | Type Subsidiary | Type Public |
Tags | |||||
Locations | Locations Cambridge, US HQ | Locations Westminster, US HQ Bannockburn, US Cranston, US | Locations Gropello Cairoli, IT HQ | Locations San Carlos, US HQ | Locations Pointe-Claire, CA HQ |
Employees | Employees 39 | Employees 106 | Employees 281 | Employees 51 | Employees 5218% increase |
Valuation ($) | Valuation ($) 227 m | Valuation ($) 117.2 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 5.8 m |
Financial | |||||
Revenue (est.) | Revenue (est.) $13.9m (FY, 2025) | Revenue (est.) $45.2m (FY, 2025) | Revenue (est.) €143.2m (Y, 2025) | Revenue (est.) $32.2m (FY, 2021) | Revenue (est.) $36.3m (FY, 2025) |
Cost of goods | Cost of goods $2.4m (FY, 2025) | Cost of goods $7m (FY, 2025) | Cost of goods N/A | Cost of goods $302k (FY, 2021) | Cost of goods $24.1m (FY, 2025) |
Gross profit | Gross profit $11.5m (FY, 2025) | Gross profit $38.2m (FY, 2025) | Gross profit N/A | Gross profit $31.9m (FY, 2021) | Gross profit $12.3m (FY, 2025) |
Net income | Net income ($79.6m) (FY, 2025) | Net income ($39.2m) (FY, 2025) | Net income €38.6m (Y, 2025) | Net income ($131.8m) (FY, 2021) | Net income ($6m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 174m | Total funding raised $ 52.2m | Total funding raised N/A | Total funding raised $ 149.5m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
TriSalus Life Sciences
HQ
Westminster, US
Employees
106
TriSalus Life Sciences (formerly MedTech Acquisition and Surefire Medical) is a company that develops a transformative platform for treating liver and pancreatic tumors.
View company
Farmabios
HQ
Gropello Cairoli, IT
Farmabios is a company that manufactures non-sterile and sterile steroids.
View companyChemoCentryx
HQ
San Carlos, US
ChemoCentryx is a biopharmaceutical company commercializing and developing medications for inflammatory and autoimmune diseases and cancer.
View companySunshine Biopharma
HQ
Pointe-Claire, CA
Employees
52↑ 18% increase
Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer.
View company